Clinical application of direct renin inhibitor aliskiren in combined therapy of patients with arterial hypertension and metabolic syndrome
- Авторлар: Dralova OV1, Maximov ML1, Ermolaeva AS1
-
Мекемелер:
- I.M. Sechenov MMA
- Шығарылым: № 4 (2010)
- Беттер: 206-208
- Бөлім: Articles
- URL: https://journals.rcsi.science/2313-0245/article/view/337473
- ID: 337473
Дәйексөз келтіру
Аннотация
The article presents the results of clinical application of direct renin inhibitor aliskiren in combination therapy in patients with arterial hypertension and obesity. The antihypertensive efficacy of aliskiren in combination with valsartan was demonstrated as dose-dependent, and was well tolerated and high safety of this combination therapy.
Авторлар туралы
O Dralova
I.M. Sechenov MMAКафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA
M Maximov
I.M. Sechenov MMAКафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA
A Ermolaeva
I.M. Sechenov MMAКафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA
Қосымша файлдар
